All news articles for October 2019

(Image: Getty/LightFieldStudios)

Amgen joins neuroscience exodus

By Ben Hargreaves

In third quarter financials, Amgen announces that it will end its R&D efforts in neuroscience to focus on diseases with a ‘large public health impact.

(Image: Getty/maxsattana)

GE Healthcare sets up UK biotech R&D lab

By Vassia Barba

GE Healthcare opens lab space to provide developers with access to protein and cell analysis technologies to encourage networking and partnering on R&D services.

(Image: Getty/BrianAJackson)

AZ’s ADC receives priority review

By Ben Hargreaves

US FDA provides AZ and Daiichi Sankyo’s ADC for the treatment of metastatic breast cancer priority review, with a decision set for Q2 2020.

(Image: Getty/Natali Mis)

Hired and Retired: Jumping on gene therapy

By Ben Hargreaves

The gene therapy space is a rapidly developing areas in the industry, as a result those with expertise are finding their knowledge is invaluable to companies looking to advance in the space.

(Image: Getty/Golubovy)

Top five stories from September

By Ben Hargreaves

The news most interesting to our readers were those featuring collaborations, whether in the production of an Ebola vaccine, biosimilars entering new markets or creating new manufacturing modalities.